Click For Photo: https://cnet2.cbsistatic.com/img/FEuykaGljc4EdPxZbywlMsnpauM=/724x407/2018/05/21/92dd4b27-f8a8-4708-98e9-0873e3417d8f/gettyimages-955234320.jpg
If you gave up a saliva swab to find out your ancestry, your genes might now be used in pharmaceutical research.
Drug giant GlaxoSmithKline will use the DNA results of gene-testing company 23andMe customers to research and design new drugs, according to a Wednesday post on 23andMe CEO Anne Wojcicki's blog. The goal is to use 23andMe's large genetic database -- it has more than 5 million customers -- to "gather insights and discover novel drug targets driving disease progression and develop therapies for serious unmet medical needs based on those discoveries," the companies said in a release.
Part - Deal - GSK
As part of the four-year deal, GSK is investing $300 million in 23andMe.
Customer participation is voluntary, Wojcicki said, and you can opt in or out at any time....
(Excerpt) Read more at: CNET
Wake Up To Breaking News!
The American Government, working tireless for everyone, except Americans.